Inventor · disambiguated record
Christian Cobaugh
Also filed as: COBAUGH CHRISTIAN · COBAUGH CHRISTIAN W · COBAUGH CHRISTIAN WESSEL
9 granted patents·9 pending applications·5 citations·filing 2016–2025
79Inventor score
Files withTRANSLATE BIO INC5MODERNATX INC3ALEXION PHARMA INC2CRISPR THERAPEUTICS AG2OMEGA THERAPEUTICS INC2
Top patents by PatentIndex Score
18 records- 0188US11559561B2Composition and methods for treatment of primary ciliary dyskinesiaTRANSLATE BIO INC·Filed 2020·Granted Jan 24, 2023·3 cites·17 claims
- 0278US11377643B2Therapeutics for glycogen storage disease type IIIULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Granted Jul 5, 2022·1 cites·20 claims
- 0376US2025057765A1Compositions, methods and uses of messenger rnaTRANSLATE BIO INC·Filed 2024·Application pending·0 cites
- 0473US12370238B2Composition and methods for treatment of primary ciliary dyskinesiaTRANSLATE BIO INC·Filed 2022·Granted Jul 29, 2025·0 cites·16 claims
- 0573US11389546B2Heterologous UTR sequences for enhanced mRNA expressionMODERNATX INC·Filed 2016·Granted Jul 19, 2022·1 cites·12 claims
- 0669US11980672B2Heterologous UTR sequences for enhanced mRNA expressionMODERNATX INC·Filed 2022·Granted May 14, 2024·0 cites·18 claims
- 0768US12188060B2Messenger RNA encoding Cas9 for use in genome-editing systemsCRISPR THERAPEUTICS AG·Filed 2021·Granted Jan 7, 2025·0 cites·15 claims
- 0866US12076438B2Compositions, methods and uses of messenger RNATRANSLATE BIO INC·Filed 2020·Granted Sep 3, 2024·0 cites·18 claims
- 0966US2022340886A1Therapeutics for glycogen storage disease type iiiULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 1058US2025145976A1Messenger rna encoding cas9 for use in genome-editing systemsCRISPR THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 1156US2024344061A1COMPOSITIONS AND METHODS FOR MODULATING HEPATOCYTE NUCLEAR FACTOR 4-ALPHA (HNF4alpha) GENE EXPRESSIONOMEGA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1251US2021145860A1Compositions, methods and uses of messenger rnaTRANSLATE BIO INC·Filed 2020·Application pending·0 cites
- 1348US11939600B2Compositions and methods for treating phenylketonuriaARCTURUS THERAPEUTICS INC·Filed 2018·Granted Mar 26, 2024·0 cites·14 claims
- 1448US2024254177A1COMPLEMENT FACTOR H AND Fc BINDING DOMAIN FUSION PROTEINSALEXION PHARMA INC·Filed 2019·Application pending·0 cites
- 1548US2022096612A1Methods for inducing immune toleranceTRANSLATEBIOINC·Filed 2019·Application pending·0 cites
- 1647US2022009979A1Fusion proteins and methods of treating complement dysregulation using the sameALEXION PHARMA INC·Filed 2019·Application pending·0 cites
- 1746US11987791B2Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (HNF4α) gene expressionOMEGA THERAPEUTICS INC·Filed 2020·Granted May 21, 2024·0 cites·37 claims
- 1836US2019307857A1MODIFIED mRNA ENCODING A URIDINE DIPHOPSPHATE GLUCURONOSYL TRANSFERASE AND USES THEREOFMODERNATX INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christian Cobaugh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →